KALV
KalVista Pharmaceuticals, Inc. · Healthcare
20.12
0.35%(-0.07)
Close20.70
2.88%(+0.58)
After HoursLast Updated: — ET
52W L: $9.2352W H: $21.30
$20.12
CHG+4.48 (+28.64%)
H$21.31
L$15.00
VOL19M
KALV (1h)
KalVista Pharmaceuticals, Inc. · Healthcare
Venrock Healthcare Capital Partners III, L.P.
10 percent owner
174,485 SH @ $16.95
2026-03-25
Venrock Healthcare Capital Partners III, L.P.
10 percent owner
160 SH @ $17.53
2026-03-25
Venrock Healthcare Capital Partners III, L.P.
10 percent owner
| 183.2M |
| 22.2M |
| 161M |
| 8.2M |
| -48M |
| 2022-04 | 203.9M | 18.8M | 185.1M | 8.2M | -22.5M |
| 2021-04 | 272M | 14.8M | 257.2M | 5.9M | -44.7M |
21,386 SH @ $17.76
2026-03-26
Venrock Healthcare Capital Partners III, L.P.
10 percent owner
15,417 SH @ $18.82
2026-03-26
Venrock Healthcare Capital Partners III, L.P.
10 percent owner
3,183 SH @ $19.12
2026-03-26
Palleiko Benjamin L
director, officer: CHIEF EXECUTIVE OFFICER
15,625 SH @ $0.00
2026-03-06
Palleiko Benjamin L
director, officer: CHIEF EXECUTIVE OFFICER
6,693 SH @ $16.08
2026-03-09
Palleiko Benjamin L
director, officer: CHIEF EXECUTIVE OFFICER
15,625 SH @ $0.00
2026-03-06